Skip to main navigation Skip to search Skip to main content

Comparative survival analysis of patients with HER2-low and HER2-positive metastatic breast cancer with or without brain metastases treated with trastuzumab deruxtecan

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Article number1036
JournalJournal of Clinical Oncology
Volume42
Issue number16
DOIs
StatePublished - 2024

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Cite this